Artigo

Phase i trial combining temozolomide plus lapatinib for the treatment of brain metastases in patients with HER2-positive metastatic breast cancer: the LAPTEM trial

JOSE ROBERTO FREITAS ROSSARI, EVANDRO DE AZAMBUJA, M.LEMORT, A. BUTTICE, V. D'HONDT, F. CARDOSO, C. SOTIRIOU, T. GIL, M. PICCART GEBHART, A. AWADA, D. ZARDAVAS, C. MOULIN, F. LEBRUN, Y. LALAMI, M. PAESMANS

Annals of Oncology Advance Access, v. 24, n. 0, p. 1-5, 2013.

Motivo: Fellowship

Setor HMV: Oncologia

Área da saúde:

Resumo: Background: Brain metastases (BMs) pose a clinical challenge in breast cancer (BC). Lapatinib or temozolomide showed activity in BM. Our study assessed the combination of both drugs as treatment for patients with HER2-positive BC and BM. Methods: Eighteen patients were enrolled, with sixteen of them having recurrent or progressive BM. Any type of previous therapy was allowed, and disease was assessed by gadolinium (Gd)-enhanced magnetic resonance imaging (MRI). The primary end points were the evaluation of the dose-limiting toxicities (DLTs) and the determination of the maximum-tolerated dose (MTD). The secondary end points included objective response rate, clinical benefit and duration of response. Results: The lapatinib–temozolomide regimen showed a favorable toxicity profile because the MTD could not be reached. The most common adverse events (AEs) were fatigue, diarrhea and constipation. Disease stabilization was achieved in 10 out of 15 assessable patients. The estimated median survival time for the 16 patients with BM reached 10.94 months (95% CI: 1.09–20.79), whereas the median progression-free survival time was 2.60 months [95% confidence interval (CI): 1.82–3.37]. Conclusions: The lapatinib–temozolomide combination is well tolerated. Preliminary evidence of clinical activity was observed in a heavily pretreated population, as indicated by the volumetric reductions occurring in brain lesions.

Envie um e-mail para os autores

© Copyright 2010 Hospital Moinhos de Vento - Todos os Direitos Reservados

Hospital Moinhos de Vento - Rua Ramiro Barcelos 910 - Bairro Moinhos de Vento - Porto Alegre - RS , CEP: 90035-001 - Fone: (51) 3314 - 3434

Hospital Moinhos de Vento Iguatemi - Shopping Iguatemi 3º andar - Porto Alegre - RS, CEP: 91340-001 - Fone: (51) 3327 - 7000

Responsável Técnico - Dr. Luiz Antonio Nasi - CREMERS 11217

Fale Conosco | Ouvidoria | Trabalhe Conosco | Localize e Visite | Mapa do Site